Rights and permissions
About this article
Cite this article
Novartis unhappy over bevacizumab decision. Pharmacoecon. Outcomes News 653, 2 (2012). https://doi.org/10.2165/00151234-201206530-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206530-00004